BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34080493)

  • 21. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
    Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
    Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug consumption of suspected drug-influenced drivers in Hungary (2016-2018).
    Institóris L; Hidvégi E; Kovács K; Jámbor Á; Dobos A; Rárosi F; Süvegh G; Varga T; Kereszty ÉM
    Forensic Sci Int; 2022 Jul; 336():111325. PubMed ID: 35569293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosing intake and rationalizing toxicities associated with 5F-MDMB-PINACA and 4F-MDMB-BINACA abuse.
    Lie W; Cheong EJY; Goh EML; Moy HY; Cannaert A; Stove CP; Chan ECY
    Arch Toxicol; 2021 Feb; 95(2):489-508. PubMed ID: 33236189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of the Synthetic Cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in Biological Matrices: A Systematic Review.
    Navarro-Tapia E; Codina J; Villanueva-Blasco VJ; García-Algar Ó; Andreu-Fernández V
    Biology (Basel); 2022 May; 11(5):. PubMed ID: 35625524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GC-MS/MS analysis of synthetic cannabinoids 5F-MDMB-PICA and 5F-CUMYL-PICA in forensic cases.
    Ahmed H; Mujeebuddin S
    Bioanalysis; 2024; 16(9):401-413. PubMed ID: 38466892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The synthetic cannabinoid 5F-MDMB-PICA enhances the metabolic activity and angiogenesis in human brain microvascular endothelial cells by upregulation of VEGF, ANG-1, and ANG-2.
    Al-Eitan LN; Alahmad SZ; ElMotasem MFM; Alghamdi MA
    Toxicol Res (Camb); 2023 Oct; 12(5):796-806. PubMed ID: 37915478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
    Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
    Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.
    Gatch MB; Forster MJ
    Neurotoxicology; 2019 Jan; 70():72-79. PubMed ID: 30439379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GC-MS Identification and Quantification of the Synthetic Cannabinoid MDMB-4en- PINACA in Cannabis-derived Material Seized in the Turin Metropolitan Area (Italy).
    Gerace E; Seganti F; Di Corcia D; Vincenti M; Salomone A
    Curr Pharm Des; 2022; 28(32):2618-2621. PubMed ID: 35658890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
    Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
    Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
    Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR
    Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Phase I Metabolism of the Recently Emerged Synthetic MDMB-4en-PINACA and Its Detection in Human Urine Samples.
    Erol Ozturk Y; Yeter O
    J Anal Toxicol; 2021 Jan; 44(9):976-984. PubMed ID: 32091101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic Profiles of 5F-MDMB-PICA in Human Urine, Serum and Hair Samples Using LC-Q Exactive HF-MS.
    Qin S; Xin G; Wei J; He G; Yuan Z; Liu H; Zhang X; Wang Y; Zhang W; Lu J
    J Anal Toxicol; 2022 Apr; 46(4):408-420. PubMed ID: 33860792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings.
    Goncalves R; Labadie M; Chouraqui S; Peyré A; Castaing N; Daveluy A; Molimard M
    Clin Toxicol (Phila); 2022 Apr; 60(4):458-463. PubMed ID: 34850659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of new psychoactive substances in Australian wastewater utilising direct injection liquid chromatography coupled to tandem mass spectrometry.
    Bade R; Eaglesham G; Shimko KM; Mueller J
    Talanta; 2023 Jan; 251():123767. PubMed ID: 35973252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs.
    Banister SD; Kevin RC; Martin L; Adams A; Macdonald C; Manning JJ; Boyd R; Cunningham M; Stevens MY; McGregor IS; Glass M; Connor M; Gerona RR
    Drug Test Anal; 2019 Jul; 11(7):976-989. PubMed ID: 30838752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA.
    Musa A; Simola N; Piras G; Caria F; Onaivi ES; De Luca MA
    Brain Sci; 2020 Dec; 10(12):. PubMed ID: 33353194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.
    Bäckberg M; Tworek L; Beck O; Helander A
    J Med Toxicol; 2017 Mar; 13(1):52-60. PubMed ID: 27638057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Identification of Synthetic Cannabinoid New Psychoactive Substances 4F-MDMB-BUTINACA and MDMB-4en-PINACA].
    Wang KD; Yuan XL; Zhang YR; Hu JJ; Cao FQ; Chen YS
    Fa Yi Xue Za Zhi; 2021 Aug; 37(4):505-510. PubMed ID: 34726003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids.
    Vučinić S; Kilibarda V; Đorđević S; Đorđević D; Perković-Vukčević N; Vuković-Ercegović G; Antonijević B; Ćurčić M; Antonijević E; Brajković G
    Arh Hig Rada Toksikol; 2018 Jun; 69(2):178-185. PubMed ID: 29990297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.